Article information
Full text is only aviable in PDF
References
[1.]
J. Morales-Torres, S. Gutiérrez-Ureña.
The burden of osteoporosis in Latin America.
Osteoporos Int., 15 (2004), pp. 625-632
[2.]
World Population Prospects. The 2006 Revision Population Database. Available at: http://esa.un.org
[3.]
The World Bank. Available at: http://web.worldbank.org
[4.]
P. Clark, P. Lavielle, F. Franco-Marina, E. Ramírez, J. Salmeron, J. Kanis, et al.
Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: A population-based study.
Osteoporos Int, 16 (2005), pp. 2025-2030
[5.]
M. Morosano, A. Masoni, A. Sanchez.
Incidence of hip fractures in the city of Rosario, Argentina.
Osteoporos Int, 16 (2005), pp. 1339-1344
[6.]
F.A. Castro da Rocha, A.R. Ribeiro.
Low incidence of hip fractures in an equatorial area.
Osteoporos Int, 14 (2003), pp. 496-499
[7.]
A. Memon, W.M. Pospula, A.Y. Tantawy, S. Abdul-Ghafar, A. Suresh, A. Al-Rowaih.
Incidence of hip fracture in Kuwait.
Int J Epidemiol, 27 (1998), pp. 860-865
[8.]
A.E. Maghraoui, B.A. Koumba, I. Jroundi, L. Achemlal, A. Bessa, M.A. Tazi.
Epidemiology of hip fractures in 2002 in Rabat, Morocco.
Osteoporos Int, 16 (2005), pp. 597-602
[9.]
J. Morales-Torres, J.A. López-García, A. Adebajo, J. Romero-Ibarra.
El impacto de la osteoporosis en África. Un reporte preliminar [abstrat].
Reumatol Clin, 4 (2008), pp. 64
[10.]
R.M. Djoumessi Zebaze, E. Seeman.
Epidemiology of hip and wrist fractures in Cameroon, Africa.
Osteoporos Int, 14 (2003), pp. 301-305
[11.]
R. Baddoura, J. Okais, H. Awada.
Incidence of fractures after the age of 50 years in the Lebanese population and implications in terms of osteoporosis.
Rev Epidemiol Sante Publique, 49 (2001), pp. 27-32
[12.]
A. Moayyeri, A. Soltani, B. Larijani, M. Naghavi, F. Alaeddini, F. Abolhassani.
Epidemiology of hip fracture in Iran: results from the Iranian Multi-center Study on Accidental Injuries.
Osteoporos Int, 17 (2006), pp. 1252-1257
[13.]
S. Rojanasthien, S. Luevitoonvechkij.
Epidemiology of hip fracture in Chiang Mai.
J Med Assoc Thai, 88 (2005), pp. S105-S109
[14.]
J. Morales-Torres, J.A. López-García, J. Romero-Ibarra, J.I. Camacho-Ochoa.
¿Cuánto cuesta tratar a mujeres con osteoporosis en México?. Estimaciones acordes a diversos umbrales de intervención [abstract].
Reumatol Clin, 4 (2008), pp. 38
[15.]
P. Clark, F. Carlos, C. Barrera, J. Guzmán, A. Maetzel, P. Lavielle, et al.
Direct costs of osteoporosis and hip fracture. An analysis for the Mexican healthcare system.
Osteoporos Int, 19 (2008), pp. 269-276
[16.]
J.A. Kanis, O. Johnell, C. de Laet, B. Jonsson, A. Oden, A.K. Ogelsby.
International variations in hip fracture probabilities: implications for risk assessment.
J Bone Miner Res, 17 (2002), pp. 1237-1244
[17.]
J. Morales-Torres.
Strategies for the prevention and control of osteoporosis in developing countries.
Clin Rheumatol, 26 (2007), pp. 139-143
[18.]
S.S. Sen, V.P. Rives, O.D. Messina, J. Morales-Torres, G. Riera, J.M. Angulo-Solimano, et al.
A risk assessment tool (OsteoRisk) for identifying latin american women with osteoporosis.
J Gen Intern Med, 20 (2005), pp. 245-249
[19.]
J.A. Kanis, F. Borgstrom, C. De Laet, H. Johansson, O. Johnell, B. Jonsson, et al.
Assessment of fracture risk.
Osteoporos Int, 16 (2005), pp. 581-589
[20.]
J. Morales-Torres.
Tratamiento farmacológico de la osteoporosis.
Avances en Osteoporosis, pp. 227-254
[21.]
S.K. Lim, A.W. Kung, S. Sompongse, S. Soontrapa, K.S. Tsai.
Vitamin D inadequacy in postmenopausal women in Eastern Asia.
Curr Med Res Opin, 24 (2008), pp. 99-106
[22.]
J.R. Elizondo-Alanís, J.R. Espinoza-Zamora, S.J. Zayas-Jaime.
Niveles séricos de vitamina D en mujeres posmenopáusicas sanas en 4 ciudades de México.
Rev Metab Oseo Min, 4 (2006), pp. 389-398
[23.]
F. Borgström, O. Johnell, J.A. Kanis, B. Jönsson.
At what hip fracture risk is it cost-effective to treat?. International intervention thresholds for the treatment of osteoporosis.
Osteoporos Int, 17 (2006), pp. 1459-1471
[24.]
I. Lekander, F. Borgström, O. Ström, N. Zethraeus, J.A. Janis.
Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK – Results based on the Women's Health Initiative randomised controlled trial.
Bone, 42 (2008), pp. 294-306
Copyright © 2008. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
